^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

mevrometostat (PF-06821497)

i
Other names: PF-06821497, PF 06821497
Associations
Trials
Company:
Pfizer
Drug class:
EZH2 inhibitor
Associations
Trials